<DOC>
	<DOCNO>NCT01161563</DOCNO>
	<brief_summary>The purpose study compare subject feel receive injection two different type GnRH six month apart . One injection give skin abdomen , one muscle buttock thigh .</brief_summary>
	<brief_title>Randomized Crossover Trial Assess Tolerability Gonadotropin Releasing Hormone ( GnRH ) Analogue Administration</brief_title>
	<detailed_description>GnRH give injection . Injections GnRH uncomfortable , cause feel burn stinging . The uncomfortable feeling may cause difference type GnRH site injection ( skin abdomen , muscle buttock thigh ) .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Male patient diagnosis advanced prostate cancer treatment triptorelin pamoate leuprolide acetate indicate ; At least 18 year age ; Life expectancy least 1 year ; Capable complete study questionnaire without assistance . Patients treatment triptorelin pamoate leuprolide acetate contraindicate ; Known hypersensitivity triptorelin , leuprolide GnRH luteinizing hormone release hormone ( LHRH ) agonists , GnRH LHRH ; Clinically significant systemic disease condition would , investigator 's opinion , lead undue risk follow administration either triptorelin leuprolide ; History alcohol/drug abuse within past year ; History significant medical problem may confound outcome study ; Requires concomitant medication may affect study assessment ( e.g. , topical medication use pretreatment injection site pain ) ; Participated another investigational drug study within 30 day Judged investigator unsuitable enrollment study reason</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>palliative treatment</keyword>
	<keyword>prostate cancer</keyword>
</DOC>